TDACU
Translational Development Acquisition Corp.
NASDAQ · Financial Services · Shell Companies · US
$11.43
−0.44%Price chart
Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29Nov 3
Key dataNov 3, 2026
Open$11.48
From 52W high−33.89%
Volume0.00
Market cap$300.68M
P/E (TTM)19.1x
P/S (TTM)—
Div yield—
Key dataNov 3, 2026
Open
$11.48
From 52W high
−33.89%
Volume
0.00
Market cap
$300.68M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−318.5x
P/E (TTM)
19.1x
RSI (14)
14.6
MomentumView details →
1D Return
−0.44%
YTD Return
+9.96%
Similar companies
Latest newsMore news →
ProLogium and Translational Development Acquisition Corp. announced a $50 million committed primary capital investment from existing ProLogium shareholders to support their business combination that will make ProLogium a publicly listed company.99d agoTranslational Development Acquisition Company announced that ProLogium has filed an F-4 with the SEC as part of their planned de-SPAC merger.121d ago